Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

Time trends of cancer mortality among elderly in Italy, 1970–2008: an observational study

Authors: Ettore Bidoli, Lucia Fratino, Silvia Bruzzone, Marilena Pappagallo, Paolo De Paoli, Umberto Tirelli, Diego Serraino

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

The aging of the Italian population will unavoidably lead to a growing number of persons diagnosed and living with cancer. A comprehensive description of the burden of cancer mortality among Italian elderly (65-84 years of age) in the last four decades has not been carried out yet. Cancer mortality rates were used to describe time trends between 1970-2008.

Methods

Mortality counts, provided by the Italian National Institute of Statistics, were grouped according to data availability: in quinquennia from 1970-74 through 1995-99, and in 2000-03 and 2006-08 groups. Age-standardized rates (world population) were computed by calendar periods while annual percent changes (APCs) were computed for elderly and middle aged (35-64 years) people for the period 1995-2008.

Results

The number of cancer deaths in elderly nearly doubled between 1970-74 (31,400 deaths/year in men, and 24,000 in women) and 2006-08 (63,000 deaths/year in men, and 42,000 in women). Overall cancer mortality rates peaked during the quinquennia 1985-89 and 1990-94 (about 1,500/100,000 in men and 680 in women) and declined thereafter. Throughout 1995-2008 cancer mortality rates decreased by -1.6%/year in men and -0.9%/year in women. These decreases were mainly driven by cancers of the stomach, bladder, prostate, and lung (APC = -3.3%, -2.7%, -2.5%, -2.2%, respectively) in men, and by cancers of the stomach, bladder, and breast (APC = -3.5%, -1.9%, -1.1%, respectively) in women. Conversely, increases in mortality rates between 1995 and 2008 were recorded for lung cancer (APC = +0.6%) in women, cutaneous melanoma (APC = +1.7%) in men, and pancreatic cancer (APC = +0.6% in men and +0.9% in women).

Conclusions

Overall favorable trends in cancer mortality were observed among Italian elderly between 1995 and 2008. Early diagnosis, improved efficacy of anti-cancer treatments and management of comorbidities are the most likely explanations of these positive observations. However, enduring preventive interventions against the most common risk factor (e.g. cigarette smoking), early diagnosis, and access to care should be reconsidered and extended to match the reductions of cancer mortality recorded in the elderly with those in the middle aged.
Appendix
Available only for authorised users
Literature
2.
go back to reference Franceschi S, LA Vecchia C: Cancer epidemiology in the elderly. Critical Rev Oncol Hematol. 2001, 39: 219-226. 10.1016/S1040-8428(01)00102-0.CrossRef Franceschi S, LA Vecchia C: Cancer epidemiology in the elderly. Critical Rev Oncol Hematol. 2001, 39: 219-226. 10.1016/S1040-8428(01)00102-0.CrossRef
3.
5.
go back to reference La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F: Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol. 2010, 21: 1323-1360. 10.1093/annonc/mdp530.CrossRefPubMed La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F: Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol. 2010, 21: 1323-1360. 10.1093/annonc/mdp530.CrossRefPubMed
6.
go back to reference Arfè A, Malvezzi M, Bertuccio P, Decarli A, La Vecchia C, Negri E: Cancer mortality trend analysis in Italy, 1970-2007. Eur J Cancer Prev. 2011, 20: 364-374. 10.1097/CEJ.0b013e328345f99e.CrossRefPubMed Arfè A, Malvezzi M, Bertuccio P, Decarli A, La Vecchia C, Negri E: Cancer mortality trend analysis in Italy, 1970-2007. Eur J Cancer Prev. 2011, 20: 364-374. 10.1097/CEJ.0b013e328345f99e.CrossRefPubMed
7.
go back to reference Levi F, La Vecchia C, Lucchini F, Negri E: Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer. 1996, 32A: 652-672.CrossRefPubMed Levi F, La Vecchia C, Lucchini F, Negri E: Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer. 1996, 32A: 652-672.CrossRefPubMed
8.
go back to reference Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C: Changed trends of cancer mortality in the elderly. Ann Oncol. 2001, 12: 1467-1477. 10.1023/A:1012539213643.CrossRefPubMed Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C: Changed trends of cancer mortality in the elderly. Ann Oncol. 2001, 12: 1467-1477. 10.1023/A:1012539213643.CrossRefPubMed
9.
go back to reference World Health Organization: International classification of disease, 8th revision. 1967, Geneva: World Health Organization World Health Organization: International classification of disease, 8th revision. 1967, Geneva: World Health Organization
10.
go back to reference World Health Organization: International classification of disease, 9th revision. 1977, Geneva: World Health Organization World Health Organization: International classification of disease, 9th revision. 1977, Geneva: World Health Organization
11.
go back to reference World Health Organization: International statistical classification of disease and related health problems, 10th revision. 1992, Geneva: World Health Organization World Health Organization: International statistical classification of disease and related health problems, 10th revision. 1992, Geneva: World Health Organization
13.
go back to reference Waterhouse J, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents. 1976, Lyon: IARC Sci Publ, 456- Waterhouse J, Muir C, Correa P, Powell J: Cancer Incidence in Five Continents. 1976, Lyon: IARC Sci Publ, 456-
14.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000, 19: 335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z. correction: 2001, 20:655CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000, 19: 335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z. correction: 2001, 20:655CrossRefPubMed
16.
go back to reference Yang L, Fujimoto J, Qiu D, Sakamoto N: Trends in cancer mortality in the elderly in Japan, 1970-2007. Ann Oncol. 2010, 21: 389-396. 10.1093/annonc/mdp303.CrossRefPubMed Yang L, Fujimoto J, Qiu D, Sakamoto N: Trends in cancer mortality in the elderly in Japan, 1970-2007. Ann Oncol. 2010, 21: 389-396. 10.1093/annonc/mdp303.CrossRefPubMed
17.
go back to reference Doll R, Peto R, Boreham J, Sutherland I: Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005, 92: 426-429.CrossRefPubMedPubMedCentral Doll R, Peto R, Boreham J, Sutherland I: Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005, 92: 426-429.CrossRefPubMedPubMedCentral
18.
go back to reference Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, La Vecchia C: Declining mortality from bladder cancer in Europe. BJU Int. 2008, 101: 11-19.PubMed Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, La Vecchia C: Declining mortality from bladder cancer in Europe. BJU Int. 2008, 101: 11-19.PubMed
19.
go back to reference Brennan P, Van der Hel O, Moore LE, Zaridze D, Matveev V, Holcatova I, Janout V, Kollarova H, Foretova L, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P: Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer. 2008, 99: 1912-1915. 10.1038/sj.bjc.6604761.CrossRefPubMedPubMedCentral Brennan P, Van der Hel O, Moore LE, Zaridze D, Matveev V, Holcatova I, Janout V, Kollarova H, Foretova L, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P: Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer. 2008, 99: 1912-1915. 10.1038/sj.bjc.6604761.CrossRefPubMedPubMedCentral
20.
go back to reference Fernandez L, Lubin JH, Muscat J, Gaudet MM, Olshan AF, Curado MP, Dal Maso L, Wunsch-Filho V, Sturgis EM, Szeszenia-Dabrowska N, Casterlsague X, Zhang ZF, Smith E, Matos E, Franceschi S, Fabianova E, Rudnai P, Purdue MP, Mates D, Wei Q, Herrero R, Kelsey K, Morgenstern H, Shangina O, Koifman S, Lissowska J, Levi F, Daudt AW, Neto JE, Chen C, Lazarus P, Winn DM, Schwartz SM, Boffetta P, Brennan P, Menezes A, La Vecchia C, McClean M, Talamini R, Rajkumar T, Hayes RB, Hashibe M: An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case–control studies. Cancer Causes Control. 2011, 22: 1217-1231. 10.1007/s10552-011-9792-x.CrossRefPubMedPubMedCentral Fernandez L, Lubin JH, Muscat J, Gaudet MM, Olshan AF, Curado MP, Dal Maso L, Wunsch-Filho V, Sturgis EM, Szeszenia-Dabrowska N, Casterlsague X, Zhang ZF, Smith E, Matos E, Franceschi S, Fabianova E, Rudnai P, Purdue MP, Mates D, Wei Q, Herrero R, Kelsey K, Morgenstern H, Shangina O, Koifman S, Lissowska J, Levi F, Daudt AW, Neto JE, Chen C, Lazarus P, Winn DM, Schwartz SM, Boffetta P, Brennan P, Menezes A, La Vecchia C, McClean M, Talamini R, Rajkumar T, Hayes RB, Hashibe M: An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case–control studies. Cancer Causes Control. 2011, 22: 1217-1231. 10.1007/s10552-011-9792-x.CrossRefPubMedPubMedCentral
21.
go back to reference Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C: Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology. 2008, 48: 137-145. 10.1002/hep.22312.CrossRefPubMed Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C: Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology. 2008, 48: 137-145. 10.1002/hep.22312.CrossRefPubMed
22.
go back to reference Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C: Dietary intake of selected micronutrients and gastric cancer risk: an Italian case–control study. Ann Oncol. 2009, 20: 160-165.CrossRefPubMed Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C: Dietary intake of selected micronutrients and gastric cancer risk: an Italian case–control study. Ann Oncol. 2009, 20: 160-165.CrossRefPubMed
23.
go back to reference Garattini S, La Vecchia C: Perspectives in cancer chemotherapy. Eur J Cancer. 2001, 37 (Suppl 8): S128-S147.CrossRefPubMed Garattini S, La Vecchia C: Perspectives in cancer chemotherapy. Eur J Cancer. 2001, 37 (Suppl 8): S128-S147.CrossRefPubMed
24.
go back to reference Rougier P, Mitry E: Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol. 2003, 14 (Suppl 2): ii3-ii5.PubMed Rougier P, Mitry E: Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol. 2003, 14 (Suppl 2): ii3-ii5.PubMed
25.
go back to reference Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA: TAX 327 Investigators: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004, 351: 1502-1512. 10.1056/NEJMoa040720.CrossRefPubMed Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA: TAX 327 Investigators: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004, 351: 1502-1512. 10.1056/NEJMoa040720.CrossRefPubMed
26.
go back to reference Boffetta P, La Vecchia C: Neoplasms. Oxford Textbook of Public Health. Edited by: Detels R, Beaglehole R, Lansang MA, Martin Gulliford M. 2009, New York: Oxford University Press, 997-1020. 5 Boffetta P, La Vecchia C: Neoplasms. Oxford Textbook of Public Health. Edited by: Detels R, Beaglehole R, Lansang MA, Martin Gulliford M. 2009, New York: Oxford University Press, 997-1020. 5
27.
go back to reference Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C, Oncology Study Group of the Italian Group of Epidemiologic Research in Dermatology: Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control. 2005, 16: 893-899. 10.1007/s10552-005-2300-4.CrossRefPubMed Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C, Oncology Study Group of the Italian Group of Epidemiologic Research in Dermatology: Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control. 2005, 16: 893-899. 10.1007/s10552-005-2300-4.CrossRefPubMed
28.
go back to reference Carbone A, Spina M, Gloghini A, Tirelli U: Classical Hodgkin’ Lymphoma arising in different host’s conditions: pathobiology parameters, therapeutic options and outcome. Am J Hematol. 2011, 86: 170-179. 10.1002/ajh.21910.CrossRefPubMed Carbone A, Spina M, Gloghini A, Tirelli U: Classical Hodgkin’ Lymphoma arising in different host’s conditions: pathobiology parameters, therapeutic options and outcome. Am J Hematol. 2011, 86: 170-179. 10.1002/ajh.21910.CrossRefPubMed
29.
go back to reference Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Ledelin P, Gisselbrecht C: CHOP chemotherapy plus rituximab compared with rCHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med. 2002, 346: 235-42. 10.1056/NEJMoa011795.CrossRefPubMed Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Ledelin P, Gisselbrecht C: CHOP chemotherapy plus rituximab compared with rCHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med. 2002, 346: 235-42. 10.1056/NEJMoa011795.CrossRefPubMed
Metadata
Title
Time trends of cancer mortality among elderly in Italy, 1970–2008: an observational study
Authors
Ettore Bidoli
Lucia Fratino
Silvia Bruzzone
Marilena Pappagallo
Paolo De Paoli
Umberto Tirelli
Diego Serraino
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-443

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine